From theheart.org on Medscape

Coverage from the

European Society of Cardiology (ESC) Congress 2021

August 27 - 30, 2021; Virtual

August 27 - 30, 2021 Virtual

ESC 2021 Micra Leadless Pacemaker Holds Up at 2 Years in Real-World Use The dime-sized device was linked to fewer reinterventions and chronic complications than traditional transvenous pacemakers among Medicare beneficiaries.
Medscape Medical News, September 3, 2021
ESC 2021 Aspirin Boosts Polypill Primary Prevention, Claims Meta-Analysis Polypills or other fixed-dose CV drug combos -- with or without aspirin, but especially with -- substantially cut risk in a meta-analysis of primary-prevention trials with a controversial message.
Medscape Medical News, September 2, 2021
Two Swings, Two Misses With Colchicine, Vascepa in COVID-19 The study cohorts varied from healthcare and public workers at high risk for infection to individuals already hospitalized with COVID-19.
Medscape Medical News, August 31, 2021

Conference News

ESC 2021 Growing Proportion of Cardiac Arrests Linked to Opioids
Medscape Medical News, September 14, 2021
ESC 2021 New ESC/EACTS Valvular Heart Disease Guidelines
Medscape Medical News, September 9, 2021
ESC 2021 Shadow of LVEF-based HF Categories Looms Over New ESC Guideline
Medscape Medical News, September 9, 2021
ESC 2021 Mediterranean Diet Tied to Less Severe Erectile Dysfunction
Medscape Medical News, September 7, 2021
ESC 2021 'Quadpill' Bests Monotherapy for Initial BP Lowering: QUARTET
Medscape Medical News, September 3, 2021
ESC 2021 STOP-DAPT 2 ACS: 1 Month of DAPT Inadequate After Recent ACS
Medscape Medical News, September 3, 2021
ESC 2021 Micra Leadless Pacemaker Holds Up at 2 Years in Real-World Use
Medscape Medical News, September 3, 2021
ESC 2021 Aspirin Boosts Polypill Primary Prevention, Claims Meta-Analysis
Medscape Medical News, September 2, 2021
ESC 2021 Antiplatelets and Anticoagulation Post-PCI: More on MASTER DAPT
Medscape Medical News, September 1, 2021
ESC 2021 Empagliflozin Win in EMPEROR-Preserved HF, but Renal Outcomes Puzzle
Medscape Medical News, September 1, 2021
ESC 2021 New ESC Guidelines on CVD Prevention
Medscape Medical News, September 1, 2021
ESC 2021 CV Safety Study of Cancer Therapy Attracts Attention
Medscape Medical News, August 31, 2021
ESC 2021 COVID Highlights Poor Outcomes in Hospitalised CLI Patients
Medscape News UK, August 31, 2021
ESC 2021 COVID-19 Strikes Double Blow in Cardiomyopathy Patients
Medscape News UK, August 31, 2021
ESC 2021 Renal Decline Slower With Rivaroxaban Than Warfarin in AF Patients
Medscape News UK, August 31, 2021
ESC 2021 Seasonal Flu Vax Cuts Post-MI Mortality: IAMI
Medscape Medical News, August 30, 2021
ESC 2021 Amulet Bests Watchman for LAAO But Not for Bleeding: AMULET-IDE
Medscape Medical News, August 30, 2021
ESC 2021 STEP: Lowering Blood Pressure Below 130 mm Hg Shows CV Benefit
Medscape Medical News, August 30, 2021
ESC 2021 Drone-Delivered Defibrillator Can Arrive Before an Ambulance
Medscape Medical News, August 30, 2021
ESC 2021 Drinking and Smoking in Youth Accelerate Arterial Stiffness
Medscape News UK, August 30, 2021

ESC 2021 Saturated Fats From Meat May Increase Cardiovascular Risk
Medscape News UK, August 30, 2021
ESC 2021 FFR Adds No Value to Angiography: RIPCORD 2
Medscape Medical News, August 29, 2021
ESC 2021 ACST-2: Carotid Stenting, Surgery on Par in Asymptomatic Patients
Medscape Medical News, August 29, 2021
ESC 2021 LOOP Trial Undercuts Long-term Continuous ECG Screening for AF
Medscape Medical News, August 29, 2021
ESC 2021 Salt Substitute Reduces Stroke, CV Events, and Death
Medscape Medical News, August 29, 2021
ESC 2021 Angiography Can Wait for Cardiac Arrest Without ST-Elevation
Medscape Medical News, August 29, 2021
ESC 2021 FIDELITY: Finerenone Cuts CV Risk in T2D Across CKD Spectrum
Medscape Medical News, August 28, 2021
ESC 2021 DECAAF II: AF, Fibrosis Ablation Falls Short, but Signs of Hope
Medscape Medical News, August 28, 2021
ESC 2021 APAF-CRT: 'Ablate and Pace' Cuts Mortality in HF, Permanent AF
Medscape Medical News, August 28, 2021
ESC 2021 'Less Is More' for Edoxaban in Post-TAVI Anticoagulation: ENVISAGE-TAVI AF
Medscape Medical News, August 28, 2021
ESC 2021 Low-to-Moderate Coffee Intake in Midlife Tied to Heart Benefits
Medscape Medical News, August 28, 2021
ESC 2021 MASTER DAPT: 1 Month DAPT Enough After High-Bleeding-Risk PCI
Medscape Medical News, August 28, 2021
ESC 2021 ICMs Detect Serious Arrhythmias in High-Risk Post-MI: SMART-MI
Medscape Medical News, August 27, 2021
ESC 2021 Dapagliflozin in HFrEF May Cut Arrhythmias, Sudden Death: DAPA-HF
Medscape Medical News, August 27, 2021
ESC 2021 EMPEROR-Preserved: Empagliflozin Scores HFpEF Breakthrough
Medscape Medical News, August 27, 2021
ESC 2021 GUIDE-HF: CardioMEMS-Guided Meds Fall Short in Mild - Moderate HF
Medscape Medical News, August 27, 2021
ESC 2021 Aerobic Exercise Can Reduce AF Frequency, Severity: ACTIVE-AF
Medscape Medical News, August 26, 2021
ESC 2021 'High Normal' Sodium, Poor Hydration Linked to Heart Failure
Medscape Medical News, August 25, 2021
ESC 2021 Hypertension Has Doubled Globally Over 30 Years
Medscape Medical News, August 25, 2021
ESC 2021 Eyes on ESC '21: Hope for EMPEROR-Preserved, Guidelines Remade
Medscape Medical News, August 23, 2021

© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Perspectives

Heart Failure Drug Management Tips and Tricks
Ileana L. Piña, MD, MPH; Carolyn Lam, MBBS, PhD
AVANTI: Could a 'Vaptan' Replace Loop Diuretics in Acute HF?
Ileana L. Piña, MD, MPH; James E. Udelson, MD
Top 5 Studies From ESC 2021
Dr Sukh Nijjer
Is 1-Month DAPT Safe? Reconciling MASTER DAPT and STOPDAPT-2
Michelle L. O'Donoghue, MD, MPH; Marco Valgimigli, MD, PhD
Implications of ACST-2 for Asymptomatic Carotid Stenosis
John M. Mandrola, MD; Richard Bulbulia, MD
Will the SSaSS Trial Silence the Salt Skeptics?
John M. Mandrola, MD; Bruce Neal, MB ChB, PhD
Ablate-and-Pace Delivers a Huge Win for Those Sick With AF
John M. Mandrola, MD
Empagliflozin in HFpEF: Putting EMPEROR-Preserved in Context
Ileana L. Piña, MD, MPH; Javed Butler, MD, MPH, MBA
Lessons on AF Screening From the LOOP Study
John M. Mandrola, MD
Incremental, Not Monumental, Win for Empagliflozin in HFpEF
John Mandrola, MD
Mandrola Previews ESC 2021
John Mandrola, MD

News from ESC 2020

DAPA-CKD: SGLT2 Inhibitor Benefits CKD Without Diabetes DAPA-CKD showed that dapagliflozin helped patients with albuminuria and declining eGFR, whether or not they also had type 2 diabetes.
Medscape Medical News, Aug 30, 2020
Final EVAPORATE Results for Vascepa Raise Eyebrows The 18-month data showed high-dose icosapent ethyl significantly cut plaque progression but did little to ease old concerns and raised only new ones.
Medscape Medical News, Sep 04, 2020
RATE-AF Trial Boosts Digoxin for Rate Control in Permanent AF Study results show equally good rate control with digoxin as with a beta-blocker, but with far fewer adverse events.
Medscape Medical News, Aug 30, 2020

Previous Coverage